Rescuing A Phase 1 Oncology Trial: Long-Standing Experience Saves Study Momentum

Often plagued with logistical hurdles and communication challenges, transitioning rescue studies from one contract research organization (CRO) to another can be difficult. After over a year into their clinical trial, one sponsor of a Phase 1 dose expansion trial for a novel oncology therapy decided they needed a new CRO partner.

Aware that the process would be inherently challenging, the sponsor contacted Premier Research. To successfully transition the study, Premier first and foremost leveraged its robust study transition Standard Operating Procedure (SOP) and associated documents. This, in conjunction with the company's long-standing expertise in oncology, speedy and flexible contracting, transparent study start-up processes, and proactive engagement to maintain study momentum, allowed the team to address client concerns while meeting expanded scope and shifting timelines.

Learn how Premier Research achieved a seamless transition and what teams should know to stay informed, keep processes aligned, and successfully transfer data.